A Method for Purification and Viral Inactivation of Human Placenta Hemoglobin

REFERENCES

• Chang, T.M.S. (2003). Artificial cells for replacement of metabolic organ functions. Artif Cells Blood Substit Immobil. Biotechnol. 31(2): 151–161, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Chang, T.M.S. (2002). Red blood cell substitutes. Artif Cells Blood Substit Immobil Biotechnol. 30(5&6): 421–437, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Yang, C.M., Li, J.Z., Ji, Y. (2001). Scientific Basis of Transfusion Medicine. University of Science and Technology of China Press: Beijing, pp. 547–568.
   Google Scholar
• Schreiber, G.B., Busch, M.P., Kleinman, S.H., Korelitz, J.J. (1996). The risk of transfusion-transmitted viral infections. New Engl. J. Med. 334(26): 1685–1690, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Nelson, Deanna J. (2002). Blood substitutes: hemoglobin-based oxygen carriers. Encyclopedia of Pharmaceutical Technology 3: 236–262, [CSA]
   Google Scholar
• Gilmore, Thomas M. (2003). “Pasteurization systems,” in Encyclopedia of Agricultural, Food, and Biological Engineering, Dennis R. Heldman, Ed., Marcel Dekker Inc., pp. 734–739.
   Google Scholar
• Azari, M., Ebeling, A., Baker, R., Burhop, K., Camacho, T., Estep, T., Guzder, S., Marshall, T., Rohn, K., Sarajari, R. (1998). Validation of the heat treatment step used in the production of diaspirin crosslinked hemoglobin (DCLHbTM) for viral inactivation. Artif Cells Blood Substit Immobil. Biotechnol. 25: 577–582, [CSA]
   Google Scholar
• Azari, M., Catarello, J., Burhop, K., Camacho, T., Ebeling, A., Estep, T., Guzder, S., Krause, K., Marshall, T., Rohn, K., Sarajari, R. (1996). Validation of the heat treatment step used in the production of diaspirin crosslinked hemoglobin (DCLHbTM) for viral inactivation-effect of crosslinking. Artif Cells Blood Substit Immobil. Biotechnol. 24(4): 303, [CSA]
   Google Scholar
• Hens, Harry J.H., Grinwis, Marc, Fokke, G., Terpstra, Bakker, Joa C. (1996). Validation of virus inactivation by pasteurization of hemoglobin solutions. Artif Cells Blood Substit Immobil. Biotechnol. 24(4): 349, [CSA]
   Google Scholar
• Estep, T.N., Bechtel, M.K., Miller, T.J., Bagdasarian, A. (1988). Virus inactivation in hemoglobin solutions by heat. Blood Substit. 16(1–3): 129–134, [CSA]
   Google Scholar
• Sakai, H., Takeoka, S., Nishide, H., Tsuchida, E. (1994). Convenient method to purify hemoglobin. Artif Cells Blood Substit Immobil Biotechnol. 22(3): 651–656, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Chang, T.M.S. (1964). Semi-permeable microcapsules. Science 146: 524–525, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Chang, T.M.S. (1997). Blood Substitutes: Principle, Methods, Products and Clinical Trials, Karger Publisher: Basel, pp. 1–141.
   Google Scholar
• Chang, T.M.S. (2000). Red blood cell substitutes. Best Pract. Res. Clin. Haematol. 13: 651–668, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Winslow, R.M. (2000). Blood substitutes. Advanced Drug Delivery Reviews 40: 131–142, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Sharma, A., Martin, M.J., Okabe, J.F., Truglio, R.A., Dhanjal, N.K., Logan, J.S., Khumar, R. (1994). An isologous porcine promoter permits high level expression of human hemoglobin in transgenic swine. Bio-Technology 12: 55–59, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Benesch, R., Benesch, R.E., Yung, S., Edalji, R. (1975). Hemoglobin covalently bridged across the polyphosphate binding site. Phys. Res. Commum. 63: 1123, [CSA]
   Google Scholar
• Drabkin, D. (1949). The standardization of hemoglobin measurement. Am. J. Med. Sci. 217: 710–711, [CSA]
   PubMed Web of Science ®Google Scholar
• Evelyn, K.A., Malloy, H.T. (1938). Microdetermination of oxyhemoglobin, methemoglobin, and sulfhemoglobin in a single sample of blood. J. Biol. Chem. 126: 655–662, [CSA]
   Google Scholar
• Agnillo, F., Alayash, A.I. (2000). Site-specific modification and toxicity of blood substitutes, the case of diaspirin cross-linked hemoglobin. Advanced Drug Delivery Reviews 40: 199–212, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Bunn, H.F., Forget, B.G. (1986). Hemoglobin: Molecular, Genetic and Clinical Aspects, W.B. Saunders Co.: Philadelphia.
   Google Scholar
• Strong, F.M., Koch, G.H. (1974). Biochemisty Laboratory Manual, WM.C. Borwn Co. Publishers: Lowa, USA, pp. 150–156.
   Google Scholar
• Wang, H.Y., Zheng, W.J., Bu, F.R., Zhu, X.X., Ma, L.R. (2001). Researches on the manufacture of blood substitute's stroma polymerized bovine hemoglobin. Chin. Pharm. J. 36(6): 416–419, [CSA]
   Google Scholar